Covid-19 Businesses for Sale and Investment

Product 1: - Digital business card platform with a worldwide directory roadmap. The business model is a low-cost subscription i. e. USD $2.99 per month and SMS enabled, no app download. New features include upload videos, calendar booking, and import contacts to CRM based on consumer demand, lead generating tool and 'data capture' so companies never lose clients or contacts with staff leaving. - AB testing results were 100 monthly subscribers under this model from 20 days Facebook advertising. If we consider the subscribers from our sister firm that is based in New Zealand, we have over 1,500 monthly subscribers. - Since COVID, it has been launched live in 5 countries in AU, NZ, US, CA, and UK. Product 2: - Peer to peer encrypted calls. We have finished beta testing and finalized the UI design. This technology will operate through any browser on a desktop, laptop and mobile. It is enabled with IP address to IP address encryption. The subscription fees range from AUD $0.99 to AUD $2.99 per month and it will be available soon in App Stores. This product will cut cost for any companies with TollCalls and TollFree calls. It encrypt uses data only. - We have the intellectual property rights for these products and they are sold under our proprietary brand. - We also have country distributor rights to ReturnMe, the world's largest global lost & found recovery company, for AU, NZ, UAE, and UK. USA and Canada as a re-seller. Their products include a digital security tag and a COVID-19 touch-aid protection product. It operates on a referral basis, white-labelled with customers entering a promo code when registering on ReturnMe. We are targeting corporates mainly. - Customer acquisition is undertaken through social media advertising for lead generating, then e-mail marketing conversion funnel. The customers that have registered for the Vcard will receive e-mail communication regarding the ReturnMe products. Our next offering will be offered as a bundle. The business receives a commission of 50% on the net profit. - We are currently undertaking a social media and digital marketing campaign on Facebook and Instagram for our Vcard services within Australia. The business has tied up with a third-party digital marketing firm for this purpose. - The business has not taken on any debt. - The EBITDA margin of the business is high since it is an asset-light model with low overheads (few salaried employees). - Run rate sales have dropped due to the ongoing Covid pandemic situation but will bounce back as it is contactless, low-cost and we have little to competitors. - The business has a high valuation expectation considering the business model, the scope of growth, and no competition with our unique offering. - The company has a separate registered entity in NZ that provides Vcard Licenses only. It has established companies in AU, UK, US (in the process), CA and NZ. Investor will be receiving a stake in the Group Holding entity. - Faster growth can be accomplished through our license partners for countries. - Director has over 25 years of business experience. They have prior experience running a txt payment parking company, mobile e-wallet / remittance, and bulk SMS engine based firms.

Staffing and placement company for hiring experienced resources in the healthcare industry. - Have 10 - 15 MNC TOP US MNC clients, and clients ' portfolios range between 4000 - 20,000+. - We are rated one of the top 3 in the US healthcare hiring industry, and meeting clients' demand within the TAT. - We hire from level 0 - very senior executive levels such as Directors, E-Directors, VPs and Sr. VPs. - Our Revenue model is 8.33% of candidates' CTC, which would range anywhere between INR 4 lakh for level with 1- 3 yrs of exp up to INR 50- 80 lakh (for leadership levels - Directors and above) - 50%+ average turnover growth for the last three years. - Steady business flow due to the rise in healthcare demand. - EBIDTA in a decreasing trend as two years post Covid was a post Covid backlog demand surge and then Normalisation phase, the last financial year. However, Still Above Pre-Pandemic Levels: EBITDA remains 3× higher than 2018–19. - Top among the competitors with our clients we work with. - Most of the clients have had relationships for more than a decade.

Located in Sarasota, this innovative business focuses on advanced air sterilization systems using cutting-edge UVGI (Ultraviolet Germicidal Irradiation) technology for whole-room air purification. - The company is currently in the pre-revenue stage, at beta-level development, with certified and lab-tested products that meet high safety and effectiveness standards. - Registered in Florida, the business holds patents on its technology and has certified electronics, offering strong competitive advantages in the growing air purification and health safety market. - It secured CAD 1.15 million in grant funding from the Canadian government to advance solutions for mitigating airborne pathogen spread, including Covid-19. - Notably, it was one of only three SMEs invited to participate in the prestigious Eureka “Innovations Without Borders” think tank, involving 14 countries, to pioneer novel technologies for sterilizing airborne pathogens in public spaces. - The air purification systems are designed for high pathogen eradication efficiency, making them ideal for public venues, healthcare facilities, and other environments demanding exceptional air quality. - The sale includes all necessary equipment, designs, and documentation, enabling a buyer to immediately begin production and sales. - Potential supply contracts are also in place to streamline manufacturing and delivery.